As Head of SRI, Hamish Chamberlayne, champions sustainability every day. It takes authenticity and a desire to take part in resolving real world issues to make any meaningful dent in environmental and social challenges.
Frank Uhlenbruch, Investment Strategist in the Janus Henderson Australian Fixed Interest team, provides his Australian economic analysis and market outlook.
US corporate profits have been inflated by stock appreciation, reduced overreporting of depreciation and government subsidies. The consensus forecast for S&P 500 earnings may understate the coming drag as these temporary influences fade.
The sector is experiencing its worst period of relative underperformance on record. But some of history’s biggest biotech pains have been followed by memorable gains.
Chris Herringshaw is Chief Technology Officer at Janus Henderson Investors, a position he has held since 2021.
A discussion of how certain fixed income categories can expose participants to unnecessary risk despite the diversification benefits they might provide.
The highly infectious variant of COVID-19 has led to rising case numbers, but we explain why a return to normalcy is still within striking distance.
The sector is experiencing its worst period of relative underperformance on record. But some of history’s biggest biotech pains have been followed by memorable gains.
Finding opportunities in the current bond environment.